Skip to content

Exploring the effects of Huangqi Oral Solution on the metabolic profile and its related potential biomarkers or pathways in healthy volunteers using RP/HILIC-UPLC-TOFMS based metabolomics approach

Metabonomics Studies on the regulation of human physiological and biochemical functions by Huangqi oral solution

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054765
Enrollment
Unknown
Registered
2021-12-26
Start date
2021-12-26
Completion date
Unknown
Last updated
2022-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

Affiliated Hospital of Nanjing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Physical health, no medical history of heart, liver, kidney, digestive tract, nervous system, mental abnormality and metabolic abnormality; 2. Between 18 and 65 years old, and the gender is not limited; 3. Body weight (calculated by body mass index = body weight (kg)/height (m^2)) between 19.0 and 26.0; 4. Informed consent, volunteer experiment. The process of obtaining informed consent should comply with GCP regulations.

Exclusion criteria

Exclusion criteria: 1. Those with evidence or symptoms of deficiency of yin and yang, such as irritability, restlessness, insomnia, dry stool, dry mouth, bad breath, etc.; 2. Take any other medication within two weeks before the trial; 3. Drugs known to be harmful to an organ have been used within three months; 4. Participate in blood donation within three months; 5. Pregnant and lactating women; 6. Suspect or have a history of alcohol or drug abuse; 7. According to the judgment of the investigator, other diseases that reduce the possibility of enrolling or complicate enrollment, such as frequent changes in the working environment, are likely to cause loss to follow-up; 8. Allergies, such as those with a history of two or more drug or food allergies; or those who are known to be allergic to the ingredients of this medicine; 9. Patients who are participating in clinical trials of other drugs.

Design outcomes

Primary

MeasureTime frame
metabolomics;

Countries

China

Contacts

Public ContactYin Jungang

Affiliated Hospital of Nanjing University of Chinese Medicine

13451861518@139.com+86 13451861518

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026